Articles

Sort by
Previous Page Page 1 of 2 Next Page
  1. Research

    Preparation in the business and practice of medicine: perspectives from recent gynecologic oncology graduates and program directors

    Preparation in the business of medicine is reported to be poor across a number of specialties. No data exist about such preparation in gynecologic oncology training programs. Our objectives were to evaluate cu...

    Matthew Schlumbrecht, John Siemon, Guillermo Morales, Marilyn Huang and Brian Slomovitz

    Gynecologic Oncology Research and Practice 2017 4:14

    Published on: 22 September 2017

  2. Research

    Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes

    Due to the significant morbidity and mortality associated with placenta percreta, alternative management options are needed. Beginning in 2005, our institution implemented a multidisciplinary strategy to patie...

    Paula S. Lee, Samantha Kempner, Michael Miller, Jennifer Dominguez, Chad Grotegut, Jessie Ehrisman, Rebecca Previs, Laura J. Havrilesky, Gloria Broadwater, Sarah C. Ellestad and Angeles Alvarez Secord

    Gynecologic Oncology Research and Practice 2017 4:11

    Published on: 22 August 2017

  3. Research

    Transversus abdominis plane block with liposomal bupivacaine compared to oral opioids alone for acute postoperative pain after laparoscopic hysterectomy for early endometrial cancer: a cost-effectiveness analysis

    To determine the cost-effectiveness of transversus abdominis plane block with liposomal bupivacaine (TAP) compared to oral opioids alone for acute postoperative pain after laparoscopic hysterectomy for early e...

    Brandon-Luke L. Seagle, Emily S. Miller, Anna E. Strohl, Anna Hoekstra and Shohreh Shahabi

    Gynecologic Oncology Research and Practice 2017 4:12

    Published on: 22 August 2017

  4. Erratum

    Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

    Dorcas Obiri-Yeboah, Yaw Adu-Sarkodie, Florencia Djigma, Kafui Akakpo, Ebenezer Aniakwa-Bonsu, Daniel Amoako-Sakyi, Jacques Simpore and Philippe Mayaud

    Gynecologic Oncology Research and Practice 2017 4:8

    Published on: 23 March 2017

    The original article was published in Gynecologic Oncology Research and Practice 2017 4:5

  5. Research

    Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial

    Palliative systemic treatment in elderly gynaecological cancer patients remains a major challenge. In recurrent ovarian cancer (ROC), treosulfan an active alkylating drug showed similar cytotoxicity whether as...

    Radoslav Chekerov, Philipp Harter, Stefan Fuxius, Lars Christian Hanker, Linn Woelber, Lothar Müller, Peter Klare, Wolfgang Abenhardt, Yoana Nedkova, Isil Yalcinkaya, Georg Heinrich, Harald Sommer, Sven Mahner, Pauline Wimberger, Dominique Koensgen-Mustea, Rolf Richter…

    Gynecologic Oncology Research and Practice 2017 4:6

    Published on: 7 March 2017

  6. Research

    Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

    Modern cervical cancer screening increasingly relies on the use of molecular techniques detecting high-risk oncogenic human papillomavirus (hr-HPV). A major challenge for developing countries like Ghana has be...

    Dorcas Obiri-Yeboah, Yaw Adu-Sarkodie, Florencia Djigma, Kafui Akakpo, Ebenezer Aniakwa-Bonsu, Daniel Amoako-Sakyi, Jacques Simpore and Philippe Mayaud

    Gynecologic Oncology Research and Practice 2017 4:5

    Published on: 3 March 2017

    The Erratum to this article has been published in Gynecologic Oncology Research and Practice 2017 4:8

  7. Case Report

    Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report

    Nivolumab is an immune checkpoint inhibitor specific for the programmed death 1 (PD-1) receptor that has led to clinical responses in many cancer types. Identifying biomarkers predictive of response to PD-1 bl...

    Sarah E. Paraghamian, Teresa C. Longoria and Ramez N. Eskander

    Gynecologic Oncology Research and Practice 2017 4:3

    Published on: 2 February 2017

  8. Review

    Clinical features and treatment of vulvar Merkel cell carcinoma: a systematic review

    Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently ...

    Austin Huy Nguyen, Ahmed I. Tahseen, Adam M. Vaudreuil, Gabriel C. Caponetti and Christopher J. Huerter

    Gynecologic Oncology Research and Practice 2017 4:2

    Published on: 25 January 2017

  9. Research

    Disparities in the surgical staging of high-grade endometrial cancer in the United States

    The National Comprehensive Cancer Network (NCCN) and the Society of Gynecologic Oncology (SGO) recommend lymph node sampling (LNS) as a key component in the surgical staging of high-grade endometrial cancer. O...

    Jonathan R. Foote, Stephanie Gaillard, Gloria Broadwater, Julie A. Sosa, Brittany Davidson, Mohamed A. Adam, Angeles Alvarez Secord, Monica B. Jones, Junzo Chino and Laura J. Havrilesky

    Gynecologic Oncology Research and Practice 2017 4:1

    Published on: 19 January 2017

  10. Research

    Genetic testing in a gynaecological oncology care in developing countries—knowledge, attitudes and perception of Nepalese clinicians

    Genetic testing for an inherited susceptibility to cancer is an emerging technology in medical practice. Little information is currently available about physicians’ attitudes towards these tests in developing ...

    Hanoon P Pokharel, Neville F Hacker and Lesley Andrews

    Gynecologic Oncology Research and Practice 2016 3:12

    Published on: 5 December 2016

  11. Research

    Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

    Chemotherapy plays a role in the treatment of endometrioid endometrial cancer (EEC); however, tumor grade may affect response. Our objective was to evaluate associations between tumor grade and in vitro chemor...

    Brittany A. Davidson, Jonathan Foote, Stacey L. Brower, Chunqiao Tian, Laura J. Havrilesky and Angeles Alvarez Secord

    Gynecologic Oncology Research and Practice 2016 3:13

    Published on: 1 December 2016

  12. Review

    The role of immune checkpoint inhibition in the treatment of ovarian cancer

    The introduction of immune checkpoint inhibitors has revolutionized treatment of multiple cancers and has bolstered interest in this treatment approach. So far, emerging clinical data show limited clinical eff...

    Stéphanie L. Gaillard, Angeles A. Secord and Bradley Monk

    Gynecologic Oncology Research and Practice 2016 3:11

    Published on: 24 November 2016

  13. Research

    Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer

    Our objective was to determine if previously reported overall survival (OS) and progression-free survival (PFS) rates are maintained long term following multimodal therapy for advanced and recurrent endometria...

    Michelle Glasgow, Rachel Isaksson Vogel, Jennifer Burgart, Peter Argenta, Kathryn Dusenbery and Melissa A. Geller

    Gynecologic Oncology Research and Practice 2016 3:6

    Published on: 26 May 2016

  14. Research

    Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

    After platinum and taxane chemotherapy, with or without bevacizumab, active regimens for advanced or recurrent cervical cancer are lacking. Our objective was to review a single institution experience in treati...

    Lindsey E. Minion, Dana M. Chase, John H. Farley, Lyndsay J. Willmott and Bradley J. Monk

    Gynecologic Oncology Research and Practice 2016 3:4

    Published on: 14 April 2016

Previous Page Page 1 of 2 Next Page